Advertisement

Topics

National Fragile X Foundation Company Profile

20:23 EDT 22nd July 2018 | BioPortfolio


News Articles [1140 Associated News Articles listed on BioPortfolio]

Ovid Therapeutics Announces Presentations Related to OV101 Fragile X Syndrome Program at the 16th National Fragile X Foundation (NFXF) International Conference

CINCINNATI, July 11, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurol...

Leading National Genetics Foundation to Present Adapted Bikes to Charlotte Area Children with ...

The annual ACMG Foundation Day of Caringis sponsored by the ACMG Foundation for Genetic and Genomic Medicine, a prominent national non-profit genetics foundation based Read more...

Fragile Antibiotic Supply Chain Causes Shortages And Is A National Security Threat

A fragile supply chain of antibiotics leads to shortages, resistance, and poses a security threat. A new white paper from Access to Medicine explains.

National Science Foundation presents FY 2019 budget request

(National Science Foundation) Today, President Donald J. Trump's Fiscal Year (FY) 2019 budget request for the National Science Foundation (NSF) was presented to Congress. More information on the FY 20...

NSF 'supermagnet' laboratory receives $184 million renewal

(National Science Foundation) The National Science Foundation (NSF) has renewed support for the National High Magnetic Field Laboratory (MagLab) with $184 million over the next five years, a funding i...

National Foundation for Cancer Research scientists among the National Academy of Inventors' class

(National Foundation for Cancer Research) Two National Foundation for Cancer Research scientists are among the National Academy of Inventors' latest class. The honor recognizes top academic inventors.

Broward Education Foundation Partners with National Center for Victims of Crime to Distribute ...

In response to the mass shooting, the Foundation, the National Center, and GoFundMe are collaborating to serve victims by maximizing resources and ensuring a victim-centered, Read more...

FDA Grants Orphan Drug Designation for Tetra Discovery Partners’ BPN14770 for the Treatment of Fragile X Syndrome

Tetra Discovery Partners today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for BPN14770 for the treatment of Fragile X Syndrome....

Drugs and Medications [503 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

Clinical Trials [1429 Associated Clinical Trials listed on BioPortfolio]

Trial of Minocycline to Treat Children With Fragile X Syndrome

This is a single center study at the UC Davis MIND Institute in patients age 3.5-16 years of age with fragile X syndrome (FXS), funded by a National Fragile X Foundation Grant. It is a con...

A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

The purpose of this study is to determine whether NNZ-2566 is safe and well tolerated in the treatment of Fragile X Syndrome in adolescent and adult males.

A Study With RO4917523 in Patients With Fragile X Syndrome

This randomized, double-blind multiple ascending dose study will evaluate the safety and tolerability, pharmacokinetics and efficacy of RO4917523 in patients with Fragile X Syndrome. The p...

A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome

This study is a controlled trial of metformin in individuals with fragile X syndrome between the ages of 6 and 25 years. Participants will be randomized in a double-blind design to either ...

Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients

This study will evaluate the safety, tolerability and efficacy of multiple doses of AFQ056 in patients with Fragile X Syndrome. The dose range will be 50 to 150 mg b.i.d. The primary read...

Companies [2334 Associated Companies listed on BioPortfolio]

The National Fragile X Foundation

National Fragile X Foundation

Tetra Discovery Partners Inc.

Tetra Discovery Partners is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Alzhe...

Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available ...

National Sleep Foundation and National Science Teachers Association

The National Sleep Foundation is dedicated to improving health and wellbeing through sleep education and advocacy. It is well known for its annual Sleep in America® poll. The F...

More Information about "National Fragile X Foundation" on BioPortfolio

We have published hundreds of National Fragile X Foundation news stories on BioPortfolio along with dozens of National Fragile X Foundation Clinical Trials and PubMed Articles about National Fragile X Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of National Fragile X Foundation Companies in our database. You can also find out about relevant National Fragile X Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record